Allred Capital Management, LLC Biogen Inc. Transaction History

Allred Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $77,441 - $123,998	-299 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $242 - $284	1 Added 0.34%	299 $83,000
Q1 2020 Apr 17, 2020	SELL	$268.85 - $341.04 $3,226 - $4,092	-12 Reduced 3.87%	298 $94.3 Million
Q4 2019 Jan 13, 2020	BUY	$220.06 - $304.07 $68,218 - $94,261	310 New	310 $91,000
Q3 2019 Oct 07, 2019	SELL	$217.44 - $243.88 $193,739 - $217,297	-891 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $109,645 - $120,860	-500 Reduced 35.95%	891 $210,000
Q1 2019 Apr 16, 2019	SELL	$216.71 - $338.96 $79,099 - $123,720	-365 Reduced 20.79%	1,391 $324,000
Q4 2018 Jan 31, 2019	BUY	$278.5 - $352.75 $489,046 - $619,429	1,756 New	1,756 $526,000

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.